Evidence of Harm

Evidence of Harm follows several parents who suspect their children's autism diagnoses may be linked to thimerosal, a mercury-based preservative used in vaccines. Author David Kirby documents their transformation from concerned parents to dedicated activists as they investigate potential connections between autism and mercury exposure. The book tracks the medical and political battles that emerged in the early 2000s around vaccine safety and autism rates. Kirby presents testimony from scientists, government officials, and medical experts on both sides of the debate, while chronicling congressional hearings and policy discussions about thimerosal. The narrative centers on the mothers and fathers who formed advocacy organizations and pressed for answers about vaccine ingredients. Their personal stories provide the framework for exploring broader questions about medical safety protocols, government oversight, and corporate influence in healthcare. Beyond the specific vaccine controversy, Evidence of Harm examines how ordinary citizens navigate complex scientific debates and challenge established medical institutions. The book raises questions about trust, evidence, and the sometimes fraught relationship between parents and the healthcare system.

Readers describe this book as a detailed investigation into the thimerosal-autism controversy, with many noting its journalistic approach to presenting different viewpoints. Positive reviews highlight: - Clear explanation of complex scientific concepts - Extensive research and documentation - Balanced presentation of both sides - Personal stories from affected families - Timeline of relevant events and policy changes Critical reviews mention: - Some readers found it too one-sided despite claims of balance - Dense scientific information can be difficult to follow - Repetitive in certain sections - Several readers felt it promoted anxiety among parents Review scores: Goodreads: 4.1/5 (416 ratings) Amazon: 4.4/5 (156 ratings) Common reader quote: "Whether you agree with the conclusions or not, the book presents important questions about vaccine safety monitoring." Multiple readers noted the book prompted them to do more research on vaccine ingredients and safety protocols, regardless of their final position on the issue.

Vaccine Epidemic by Barbara Loe Fisher, Louise Kuo Habakus. A collection of research and personal accounts examining vaccination policies and their impacts on public health.

The Age of Autism by Dan Olmsted and Mark Blaxill. An investigation into the history of autism and environmental factors through case studies and medical records.

Plague by Kent Heckenlively, Judy Mikovits. A scientific examination of chronic diseases and their potential links to environmental toxins and medical practices.

The HPV Vaccine on Trial by Mary Holland, Kim Mack Rosenberg, and Eileen Iorio. An analysis of clinical trials, scientific studies, and documented cases related to HPV vaccination programs.

Science for Sale by David L. Lewis. An inside look at the relationship between government agencies, corporations, and scientific research in public health policy.

🔬 Author David Kirby spent three years investigating the potential link between thimerosal (a mercury-based preservative) and autism, conducting over 400 interviews with scientists, government officials, and families. 💉 The book's publication in 2005 helped spark a national debate about vaccine safety and led to congressional hearings on the topic of mercury in vaccines. 📊 While researching the book, Kirby discovered that the amount of ethylmercury exposure to infants through vaccinations had tripled between 1988 and 1992 due to changes in the vaccination schedule. 🏆 Evidence of Harm was a finalist for the New York Public Library Helen Bernstein Book Award for Excellence in Journalism and received the Investigative Reporters and Editors Award for Outstanding Investigation. 🌍 The book has been translated into six languages and became a catalyst for similar investigations in other countries, particularly in the UK and Scandinavia, where vaccination policies were subsequently reviewed.